Canertinib

Canertinib

Canertinib (pronounced: ka-ner-ti-nib) is a type of chemotherapy drug that is used in the treatment of certain types of cancer. It is a tyrosine kinase inhibitor, which works by blocking certain proteins in the body that can contribute to the growth and spread of cancer cells.

Etymology

The name "Canertinib" is derived from the words "cancer" and "tyrosine kinase inhibitor", reflecting its use and mechanism of action. The suffix "-nib" is commonly used in the names of tyrosine kinase inhibitors.

Usage

Canertinib is used in the treatment of various types of cancer, including breast cancer, lung cancer, and colorectal cancer. It is typically used when other treatments have not been effective.

Side Effects

Like all chemotherapy drugs, Canertinib can cause side effects. These may include nausea, vomiting, diarrhea, and fatigue. More serious side effects can include heart problems, liver problems, and skin reactions.

Related Terms

• Chemotherapy
• Tyrosine kinase inhibitor
• Cancer
• Breast cancer
• Lung cancer
• Colorectal cancer
• Nausea
• Vomiting
• Diarrhea
• Fatigue
• Heart problems
• Liver problems
• Skin reactions

External links

• Medical encyclopedia article on Canertinib
• Wikipedia's article - Canertinib

This WikiMD article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski